M&A Deal Summary

Smith & Nephew Acquires OsteoBiologics

On July 11, 2006, Smith & Nephew acquired medical products company OsteoBiologics from Ivy Capital Partners for 72M USD

Acquisition Highlights
  • This is Smith & Nephew’s 6th transaction in the Medical Products sector.
  • This is Smith & Nephew’s 14th largest (disclosed) transaction.
  • This is Smith & Nephew’s 1st transaction in Germany.

M&A Deal Summary

Date 2006-07-11
Target OsteoBiologics
Sector Medical Products
Buyer(s) Smith & Nephew
Sellers(s) Ivy Capital Partners
Deal Type Add-on Acquisition
Deal Value 72M USD

Target

OsteoBiologics

Wermelskirchen, Germany
website
OsteoBiologics, Inc. located in San Antonio, Texas, develops and manufactures bioabsorbable polymeric scaffolds, films, and related instrumentation for the repair and replacement of bone and articular cartilage. In July 2006, the Company was sold to Smith & Nephew plc for $72.3 million.

Search 190,634 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Smith & Nephew

Watford, United Kingdom

website


Category Company
Founded 1856
Sector Medical Products
Employees18,000
Revenue 5.2B USD (2022)
DESCRIPTION

Smith & Nephew is a British-based multinational medical equipment manufacturing company. Smith & Nephew was founded in 1856 and is based in Watford, the United Kingdom.


DEAL STATS #
Overall 7 of 34
Sector (Medical Products) 6 of 23
Type (Add-on Acquisition) 6 of 25
Country (Germany) 1 of 2
Year (2006) 1 of 1
Size (of disclosed) 14 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-05-31 Smith & Nephew - Dermagraft Product

United Kingdom

Smith & Nephew - Dermagraft Product is intended for the treatment of diabetic foot ulcer.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-03-12 Plus Orthopedics Holding AG

Rotkreuz, Switzerland

PlusOrthopedics Holding AG. is a orthopedic company with over 850 employees providing implants and technically advanced surgical solutions. Plus has focused its activities on the development of implants for hips, knees, shoulders and small joints.

Buy $889M

Seller(S) 1

SELLER

Ivy Capital Partners

Montvale, New Jersey, United States

website


Category Private Equity Firm
Founded 2002
Size Small
Type Sector Focused
DESCRIPTION

Ivy Capital Partners is a specialized private equity firm that seeks investments in companies that operate in the musculoeskeletal sector of the healthcare industry. Specific areas of interest within the musculoskeletal sector include sports medicine, joint implants, rehabilitation products and services, trauma, spine and therapeutics. The Firm will consider both mid to later stage investment situations. Ivy Capital Partners is a unit of investment firm Ivy Equities and is based in Montvale, New Jersey.


DEAL STATS #
Overall 1 of 12
Sector (Medical Products) 1 of 10
Type (Add-on Acquisition) 1 of 9
Country (Germany) 1 of 2
Year (2006) 1 of 1
Size (of disclosed) 1 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2005-08-08 MAKO Surgical

Ft. Lauderdale, Florida, United States

MAKO provides an advanced robotic solution and orthopedic implants for minimally invasive orthopedic knee procedures. MAKO's proprietary cleared, FDA robotic surgery system offers surgeons patient-specific visualization and the tools to safely treat early to mid-stage osteoarthritic knee disease in a reproducible manner.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-20 Gentis

Wayne, Pennsylvania, United States

Gentis develops synthetic products that represent fundamental improvements for treating degenerated intervertebral discs of the spine and other musculoskeletal lesions. The Company has developed a proprietary material whose unique characteristics make it ideally suited for use in the spine. In the longer-term Gentis' broad technology platform also creates a broad-based product orthobiologics pipeline. Gentis was founded in 2000 and is based in Wayne, Pennsylvania.

Buy -